← Back to all signals
RESEARCH PAPER ANALYSIS

New staging criteria predicting m-tor inhibitors treatment effect of renal angiomyolipoma in tuberous sclerosis complex patients.

AI interpretation is pending for this paper.

Open original publication →
PMID39302433
JournalWorld journal of urology
Publication Date2024-09-20
Ingested2026-08-02 12:02 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: We aimed to launched new staging criteria to predict mTOR inhibitors treatment effect of renal angiomyolipomas (r-AMLs) in TSC patients. METHODS: 40 TSC patients with 69 r-AMLs were divided into two groups based on the efficacy of 6-month mTOR inhibitor treatment. Epidemiological data, therapeutic response, and predictive factors of enrolled patients were collected and analyzed. Age, sex, maximum diameter, maximum cross-sectional area (CSAmax), unenhanced mean CT value, enhanced mean CT value, and added value of enhanced CT of largest r-AML at baseline were assessed as potential influencing factors. Receiver operating characteristic (ROC) curve analysis and the area under the ROC curve (AUC) was used to estimate prediction power. RESULTS: After 6 months of mTOR inhibitor treatment, the tumor reduction rates in the two groups were 55.87% and 16.44% (P < 0.001). At the start of treatment, the maximum diameters, CSAmax, added value of enhanced CT of the target lesion in two groups were 7.70 ± 0.73 cm vs. 13.18 ± 1.23 cm(P = 0.028), 57.40 ± 10.76cm2 vs. 167.29 ± 33.09cm2 (P = 0.015), and 62.32 ± 5.03HU vs. 33.06 ± 3.13HU (P = 0.009), respectively. AUCs of CSAmax, added value of enhanced CT, and combination of both were 0.8024, 0.7672, and 0.8116, respectively (P < 0.001). Cut-off values of CSAmax combined with the added value of enhanced CT were 40cm2 and 46HU. AUCs of maximum diameters, combination of maximum diameters and added value of enhanced CT were 0.7600 and 0.8100, respectively (P < 0.001), with cut-off values of 6.6 cm and 46 HU. CONCLUSION: New staging criteria, based on CSAmax and added value of enhanced CT, can predict the treatment efficiency of m-TOR inhibitors for r-AMLs in TSC patients. A simplified version based on maximum diameter and added value of enhanced CT of lesion has also been proposed.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Nasopharyngeal Branchial Cleft Cyst in an Elderly Man: An Atypical Presentation. Iranian journal of otorhinolaryngology 55.5 2 A Cross-Sectional Study of Women's Cervical Cancer Knowledge and Acceptance of Human Papillomavirus Vaccination in Makeni, Sierra Leone. Journal of health care for the poor and underserved 59.5 3 Correction to: The effect of centralized care on the management of postoperative fluctuations in plasma sodium concentration after pediatric suprasellar brain tumor surgery. Pituitary 47.5 4 Tumor Number and Model for End-Stage Liver Disease Score as Selection Criteria for Resection or Embolization of Intermediate-Stage Hepatocellular Carcinoma. Cancer reports (Hoboken, N.J.) 57.2 5 Engineered flavonoid disrupts mitochondrial AIF/CHCHD4 complex for targeted cancer therapy. Acta pharmaceutica Sinica. B 55.54 6 Clinical Characteristics and Long-Term Follow-Up of Leukoencephalopathy in Pediatric Acute Lymphoblastic Leukemia After Chemotherapy. Cancer management and research 65.84 7 Sex and age at exposure influence 131I biodistribution and dosimetry in Sprague-Dawley rats. Biology of sex differences 62.3 8 Distress Screening and Pediatric Palliative Care Referral: A Retrospective Case-Control Study in Supportive Cancer Care Delivery. Journal of palliative medicine 67.0 9 A qualitative study exploring the pros and cons of universal pediatric palliative care referral at diagnosis for children with cancer - CORRIGENDUM. Palliative & supportive care 47.5 10 Anesthesia in the Ophthalmology Clinic for Infants Younger Than 1 Year Undergoing Retinoblastoma Treatment. Review of 888 Cases. Paediatric anaesthesia 69.74 11 Comprehensive In Vitro Profiling Demonstrates Successful Immune Evasion of Bioengineered Immune-Shielded Heart Valves. Advanced healthcare materials 50.7 12 Comparative Effectiveness of Antibiotic Prophylaxis Regimens in Pediatric Acute Myeloid Leukemia. Pediatric blood & cancer 64.3 13 The Impact of the COVID-19 Pandemic on Childhood Cancer Survival: A Population-Based Assessment of Survival Patterns Between 2015 and 2023 in Germany. Pediatric blood & cancer 69.52 14 A Phase I/II Trial of Anti-CD22/CD19 CAR-T Cell Therapy, CART2219.1, in Adult and Pediatric Relapsed/Refractory B-ALL. Blood cancer discovery 85.96 15 Radiomics and machine learning for differentiating pediatric intramedullary spinal tumors: a pilot study. European radiology experimental 65.0 16 Intracranial germ cell tumors: an underrecognized diagnostic consideration in adults with sellar/suprasellar lesions. Journal of neuro-oncology 65.5 17 Psychosocial interventions for children and adolescents across the cancer care continuum: A systematic review and meta-analysis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 83.5 18 Ovarian Dysfunction After Gonadotoxic Therapy in Childhood Cancer Survivors: A Cross-Sectional Study From a Resource-Limited Setting. Journal of pediatric hematology/oncology 68.34 19 Self-Efficacy and Knowledge in Cardiotoxicity Management Among Pediatric Oncology Nurses: A Cross-Sectional Mediation Analysis. Journal of pediatric hematology/oncology 63.02 20 Derivation of a dose descriptor for the internal exposure to benzene. International journal of hygiene and environmental health 58.62 21 From childhood trauma to adult health: The association between adverse childhood experiences and preventive healthcare screenings. Journal of epidemiology and population health 38.5 22 Pyroptosis-Related Pathways and Their Impact on Immune Microenvironment Remodeling in Pediatric Ovarian and Adnexal Tumors. Experimental cell research 55.3 23 Expanding Horizons in Fertility Preservation: Diverse Populations, Emerging Indications, and Ethical Considerations. Fertility and sterility 62.8 24 Herbal medicine among vulnerable populations in Cameroon: a systematic review and meta-analysis with clinical, mechanistic, and global health perspectives. Journal of ethnopharmacology 74.0 25 Diagnostic accuracy of growth hormone stimulation tests for growth hormone deficiency following radiotherapy involving the hypothalamic-pituitary axis: protocol for a systematic review and planned meta-analysis. BMJ open 84.74 26 Asynchronous bilateral pulmonary pathology: left-sided congenital pulmonary airway malformation with contralateral malignant pleuropulmonary blastoma in an adolescent. BMJ case reports 58.4 27 Hereditary TTP and Hemolytic Anemia in Newborns. Pediatrics 60.9 28 Thymic age and peripheral residence time determine antitumor competence of CD8+ T cells. Proceedings of the National Academy of Sciences of the United States of America 58.4 29 Population Pharmacokinetics of Topical Timolol Maleate Gel in Healthy Volunteers and Infants With Superficial Infantile Hemangioma. CPT: pharmacometrics & systems pharmacology 75.9 30 Global Trends in Sun Safety and Skin Cancer Prevention Education Among Adolescents: A Bibliometric Analysis. Cureus 58.0 31 Development and Validation of an Interpretable Machine Learning Model for Predicting Early Pulmonary Metastasis Risk in Osteosarcoma. Cancer medicine 66.3 32 Financial toxicity among families of children with cancer: a qualitative systematic review and meta-aggregation. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 77.52
PATIENT-FRIENDLY SUMMARY

New staging criteria predicting m-tor inhibitors treatment effect of renal angiomyolipoma in tuberous sclerosis complex patients.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic